• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ChemoMetec

463.20 DKK-2.93 %14.8, 16.59
Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-2.93 %
+13.20 %
+47.80 %
+14.82 %
-32.63 %
-6.16 %
+7.62 %
-48.76 %
+2,005.45 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
8.06B DKK
Turnover
69.54M DKK
Revenue
495.57M
EBIT %
47.73 %
P/E
43.25
Dividend yield-%
1.51 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.9
2026

Annual report '26

8.10
2026

General meeting '26

3.2
2027

Interim report Q2'27

Regulatory press release10.08.2026, 12.32

ChemoMetec enters collaboration agreement with Roche Diagnostics

ChemoMetec
Press release07.08.2026, 15.04

ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report

ChemoMetec
Press release07.08.2026, 15.04

ChemoMetec A/S afholder telefonkonference den 11. september 2026 kl. 15.00 til præsentation af den kommende årsrapport for 2025/26

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release01.08.2026, 10.24

Appointment of new CFO

ChemoMetec
Regulatory press release01.08.2026, 10.24

Udnævnelse af ny CFO

ChemoMetec
HCA Morgenbørs 26/05 - Lukkede markeder ser ud til at skulle catche op på mandagens stigninger
Video26.05.2026, 09.13 by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 26/05 - Lukkede markeder ser ud til at skulle catche op på mandagens stigninger

I dagens Morgenbørs ser vi ind i blandede futures fra morgenstunden. Herhjemme, lukkede markeder ser ud til at skulle catche op på mandagens stigninger.

ChemoMetecRockwoolGrønlandsbankenTCM GroupLundbeckNovo Nordisk
HCA Morgenbørs 18/05 - Negative futures og lange renter stiger
Video18.05.2026, 09.18 by
Michael Friis, Victor Skriver

HCA Morgenbørs 18/05 - Negative futures og lange renter stiger

I dagens Morgenbørs ser vi ind i negative futures, lange renter stiger. Herhjemme er der fokus på Novo, NKT, RTX og Chemometec.

NKTChemoMetecA.P. Møller - MærskRTXNovo NordiskGN Store NordColoplastTorm
Regulatory press release15.05.2026, 11.43

Initiation of buy-back programme

ChemoMetec
Regulatory press release15.05.2026, 11.43

Iværksættelse af aktietilbagekøbsprogram

ChemoMetec
HCA Morgenbørs 07/05 - Fokus på danske regnskaber
Video07.05.2026, 09.24 by
Victor Skriver, Michael Friis

HCA Morgenbørs 07/05 - Fokus på danske regnskaber

I dagens Morgenbørs ser vi ind i et positivt futuresmarked, drevet af rygter om, at Iran og USA er ved at nå til enighed. Herhjemme er der endnu en regnskabsdag i vente med regnskaber fra bl.a. Mærsk, Zealand Pharma, GN Store Nord og ChemoMetec.

A.P. Møller - MærskNovo NordiskZealand PharmaChemoMetecGomSpaceGN Store Nord
Regulatory press release06.05.2026, 18.52

Vækst i omsætning og driftsresultat

ChemoMetec
Regulatory press release06.05.2026, 18.52

Growth in revenue and operating profit

ChemoMetec
Regulatory press release04.05.2026, 15.17

Tilpasning af regnskabsmæssigt skøn bidrager til opjustering af omsætning og driftsresultat

ChemoMetec
Regulatory press release04.05.2026, 15.17

Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release27.03.2026, 10.06

Notification of managers’ transactions

ChemoMetec
Regulatory press release27.03.2026, 10.06

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release27.03.2026, 09.53

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release27.03.2026, 09.53

Notification of managers’ transactions

ChemoMetec
Regulatory press release26.03.2026, 11.40

Notification of managers’ transactions

ChemoMetec
Regulatory press release26.03.2026, 11.40

Indberetning af ledende medarbejderes transaktioner

ChemoMetec